Viewing Study NCT00126620


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2025-12-26 @ 3:05 AM
Study NCT ID: NCT00126620
Status: COMPLETED
Last Update Posted: 2015-07-23
First Post: 2005-08-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module